Quarterly report pursuant to Section 13 or 15(d)

Related Party Transactions (PIK Dividend or Equity Fee Payable) (Details)

v3.21.1
Related Party Transactions (PIK Dividend or Equity Fee Payable) (Details)
 3 Months Ended
Feb. 08, 2019
Mar. 31, 2021
Helocyte [Member]    
Related Party Transaction [Line Items]    
Effective date   Mar. 20, 2015
PIK dividend as a percentage of fully diluted outstanding capitalization   2.50%
Avenue [Member]    
Related Party Transaction [Line Items]    
Effective date   Feb. 17, 2015
PIK dividend as a percentage of fully diluted outstanding capitalization   0.00%
Mustang [Member]    
Related Party Transaction [Line Items]    
Effective date   Mar. 13, 2015
PIK dividend as a percentage of fully diluted outstanding capitalization   2.50%
Checkpoint [Member]    
Related Party Transaction [Line Items]    
Effective date   Mar. 17, 2015
PIK dividend as a percentage of fully diluted outstanding capitalization   0.00%
Annual equity fee as a percentage of fully diluted outstanding capitalization   2.50%
Cellvation [Member]    
Related Party Transaction [Line Items]    
Effective date   Oct. 31, 2016
PIK dividend as a percentage of fully diluted outstanding capitalization   2.50%
Baergic [Member]    
Related Party Transaction [Line Items]    
Effective date   Dec. 17, 2019
PIK dividend as a percentage of fully diluted outstanding capitalization   2.50%
Cyprium [Member]    
Related Party Transaction [Line Items]    
Effective date   Mar. 13, 2017
PIK dividend as a percentage of fully diluted outstanding capitalization   2.50%
Aevitas [Member]    
Related Party Transaction [Line Items]    
Effective date   Jul. 28, 2017
PIK dividend as a percentage of fully diluted outstanding capitalization   2.50%
Oncogenuity [Member]    
Related Party Transaction [Line Items]    
Effective date   Apr. 22, 2020
Dividends Paid in kind percentage   2.50%
FBIO Acquisition Corp VIII [Member]    
Related Party Transaction [Line Items]    
Effective date   Nov. 07, 2017
PIK dividend as a percentage of fully diluted outstanding capitalization   0.00%
Minimum [Member] | InvaGen [Member] | SPMA [Member] | Avenue [Member]    
Related Party Transaction [Line Items]    
Percentage of common shares acquired in the Stock Purchase Transaction for the rights to exist 75.00%